Abatacept (CTLA-4IG) treatment reduces the migratory...

Arthritis & Rheumatism 2013 / 03 Vol. 65; Iss. 3

Abatacept (CTLA-4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis

Bonelli, M., Ferner, E., Göschl, L., Blüml, S., Hladik, A., Karonitsch, T., Kiener, H. P., Byrne, R., Niederreiter, B., Steiner, C. W., Rath, E., Bergmann, M., Smolen, J. S., Scheinecker, C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
65
Language:
english
Journal:
Arthritis & Rheumatism
DOI:
10.1002/art.37787
Date:
March, 2013
File:
PDF, 381 KB
english, 2013
Conversion to is in progress
Conversion to is failed